Results 141 to 150 of about 15,175 (215)

Novel germline <i>JAK2 L808W</i> and <i>E305Vfs*4</i> mutations in familial essential thrombocythemia: Evidence from two pedigrees. [PDF]

Chin J Cancer Res
Liu J, Hu W, Wang C, Zhang Y, Ouyang M, Ren H, Zhang M.   +6 more
europepmc   +1 more source

Hantavirus Infections-Clinical Recognition and Diagnostic Challenges. [PDF]

Lancet Reg Health Eur
Kraft L, Latus J.
europepmc   +1 more source

Optimized post-GWAS analysis identifies therapeutic targets for essential thrombocythemia and polycythemia vera. [PDF]

Commun Med (Lond)
Li X, An W, Wang X, Yin Z, Gao Y, Lan Y, Zhang L, Zhao B, Chang L, Ruan M, Zhang L, Zou Y, Yang W, Zhu X.   +13 more
europepmc   +1 more source

Delayed Splenial Artery Pseudoaneurysm After Angiographically Negative Intracerebral Hemorrhage: A Case Report. [PDF]

Cureus
Ueda K, Mitsutake T, Kadooka K, Tanaka M.   +3 more
europepmc   +1 more source

Acute STEMI in a young adult without conventional risk factors: a case report of JAK2-positive essential thrombocythemia. [PDF]

Eur Heart J Case Rep
Chen DM, Shin ED, Lee E, Xu L, Enders CL.   +4 more
europepmc   +1 more source

Between the classic hit and the modern sequel: transition dosing between peginterferon alfa-2a and ropeginterferon alfa-2b for myeloproliferative neoplasms. [PDF]

Ann Hematol
Abu-Zeinah G, Hobbs G, Reeves BN, Yacoub A, Scandura JM.   +4 more
europepmc   +1 more source

4G/5G polymorphism and plasma levels of plasminogen activator inhibitor-1 in essential thrombocythemia patients with driver mutational status. [PDF]

Thromb J
Zhang X, Guo X.
europepmc   +1 more source

DARS expression in JAK2V617F-positive myeloproliferative neoplasms: immunohistochemical analysis and clinical associations. [PDF]

Ann Hematol
Arafat AMA, Ghaffar HAA, Khallaf AM, Younes SAM, Morad MA, Mahgoub SMA.   +5 more
europepmc   +1 more source

Clinical Associations of Osteoporosis in BCR::ABL1 Negative Myeloproliferative Neoplasms. [PDF]

Int J Endocrinol
Aydin MS, Dagdas S, Pepeler MS, Korkmaz G, Alper A, Açıkgöz E, Bektas TN, Pamukçuoğlu M, Ceran F, Ozet G.   +9 more
europepmc   +1 more source

Application of NanoString Technologies in Chronic Myeloid Leukemia, Essential Thrombocythemia, Primary Myelofibrosis, and Polycythemia Vera: A Pilot Study. [PDF]

Diagnostics (Basel)
Bae JH, Bae KJ, Cho CH.
europepmc   +1 more source